Journal
KIDNEY INTERNATIONAL
Volume 76, Issue 9, Pages 999-1005Publisher
ELSEVIER SCIENCE INC
DOI: 10.1038/ki.2009.305
Keywords
chloride/proton exchanger; ClC-5; Dent's disease; mutation
Categories
Funding
- French ANR program [ANR-05-MRAR-033-01]
- UPMC-Universite Paris 06
Ask authors/readers for more resources
Dent's disease is an X-linked recessive disorder affecting the proximal tubules and is frequently associated with mutations in CLCN5, which encodes the electrogenic chloride-proton exchanger ClC-5. To better understand the functional consequences of CLCN5 mutations in this disease, we screened four newly identified missense mutations (G179D, S203L, G212A, L469P), one new nonsense mutation (R718X), and three known mutations (L200R, C219R, and C221R), in Xenopus laevis oocytes and HEK293 cells expressing either wild-type or mutant exchanger. A type-I mutant (G212A) trafficked normally to the cell surface and to early endosomes, underwent complex glycosylation at the cell surface like wild-type ClC-5, but exhibited significant reductions in outwardly rectifying ion currents. The type-II mutants (G179D, L200R, S203L, C219R, C221R, L469P, and R718X) were improperly N-glycosylated and were nonfunctional due to retention in the endoplasmic reticulum. Thus these mutations have distinct mechanisms by which they could impair ClC-5 function in Dent's disease. Kidney International (2009) 76, 999-1005; doi:10.1038/ki.2009.305; published online 5 August 2009
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available